Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Choosing healthy embryos in IVF

07.05.2002


A revolutionary method for detecting which human embryos are most likely to develop successfully to the stage at which they implant in the womb has been developed by scientists at the University of York and clinicians at Leeds General Infirmary.


The research has been funded by the Medical Research Council.

The discovery, if confirmed in clinical trials, could bring new hope for many couples undergoing fertility treatment since current failure rates are high. One of the problems is that embryos for replacement in the womb are currently judged by eye under the microscope but this method has not proved particularly successful in predicting their potential to give rise to a pregnancy.

The new method has been developed by Professor Henry Leese and colleagues in the Department of Biology at the University of York, together with members of the IVF Unit (In Vitro Fertilisation) at Leeds General Infirmary. Two days after fertilisation, embryos are placed in a culture medium containing amino acids and monitored in the laboratory to see how they consume or produce these amino acids.



Professor Leese said: “We’ve found a marked difference between the embryos which develop successfully in culture and those which do not. The healthy embryos have a ‘quieter’ metabolism.

‘The method is completely non-invasive and does not harm the embryos in any way. It opens up the prospect of selecting high-quality embryos to replace into the womb, increasing success rates, reducing the financial and emotional cost to patients and greatly eliminating the risk of multiple births. If all goes well with the clinical trials, we hope to have a diagnostic test for use in clinics in two or three years’ time.”

Professor Leese is a member of the Human Fertilisation and Embryology Authority (HFEA) which regulates, licenses and collects data on fertility treatments such as IVF and donor insemination, as well as human embryo research, in the UK.

Professor Henry Leese | alphagalileo

More articles from Life Sciences:

nachricht Symbiotic bacteria: from hitchhiker to beetle bodyguard
28.04.2017 | Johannes Gutenberg-Universität Mainz

nachricht Nose2Brain – Better Therapy for Multiple Sclerosis
28.04.2017 | Fraunhofer-Institut für Grenzflächen- und Bioverfahrenstechnik IGB

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Making lightweight construction suitable for series production

More and more automobile companies are focusing on body parts made of carbon fiber reinforced plastics (CFRP). However, manufacturing and repair costs must be further reduced in order to make CFRP more economical in use. Together with the Volkswagen AG and five other partners in the project HolQueSt 3D, the Laser Zentrum Hannover e.V. (LZH) has developed laser processes for the automatic trimming, drilling and repair of three-dimensional components.

Automated manufacturing processes are the basis for ultimately establishing the series production of CFRP components. In the project HolQueSt 3D, the LZH has...

Im Focus: Wonder material? Novel nanotube structure strengthens thin films for flexible electronics

Reflecting the structure of composites found in nature and the ancient world, researchers at the University of Illinois at Urbana-Champaign have synthesized thin carbon nanotube (CNT) textiles that exhibit both high electrical conductivity and a level of toughness that is about fifty times higher than copper films, currently used in electronics.

"The structural robustness of thin metal films has significant importance for the reliable operation of smart skin and flexible electronics including...

Im Focus: Deep inside Galaxy M87

The nearby, giant radio galaxy M87 hosts a supermassive black hole (BH) and is well-known for its bright jet dominating the spectrum over ten orders of magnitude in frequency. Due to its proximity, jet prominence, and the large black hole mass, M87 is the best laboratory for investigating the formation, acceleration, and collimation of relativistic jets. A research team led by Silke Britzen from the Max Planck Institute for Radio Astronomy in Bonn, Germany, has found strong indication for turbulent processes connecting the accretion disk and the jet of that galaxy providing insights into the longstanding problem of the origin of astrophysical jets.

Supermassive black holes form some of the most enigmatic phenomena in astrophysics. Their enormous energy output is supposed to be generated by the...

Im Focus: A Quantum Low Pass for Photons

Physicists in Garching observe novel quantum effect that limits the number of emitted photons.

The probability to find a certain number of photons inside a laser pulse usually corresponds to a classical distribution of independent events, the so-called...

Im Focus: Microprocessors based on a layer of just three atoms

Microprocessors based on atomically thin materials hold the promise of the evolution of traditional processors as well as new applications in the field of flexible electronics. Now, a TU Wien research team led by Thomas Müller has made a breakthrough in this field as part of an ongoing research project.

Two-dimensional materials, or 2D materials for short, are extremely versatile, although – or often more precisely because – they are made up of just one or a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Fighting drug resistant tuberculosis – InfectoGnostics meets MYCO-NET² partners in Peru

28.04.2017 | Event News

Expert meeting “Health Business Connect” will connect international medical technology companies

20.04.2017 | Event News

Wenn der Computer das Gehirn austrickst

18.04.2017 | Event News

 
Latest News

Wireless power can drive tiny electronic devices in the GI tract

28.04.2017 | Medical Engineering

Ice cave in Transylvania yields window into region's past

28.04.2017 | Earth Sciences

Nose2Brain – Better Therapy for Multiple Sclerosis

28.04.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>